15 February 2017 | M. Fata Moradali, Shirin Ghods and Bernd H. A. Rehm
Pseudomonas aeruginosa is a versatile and opportunistic pathogen that causes significant morbidity and mortality, particularly in immunocompromised patients and those with cystic fibrosis (CF). Its ability to adapt, survive, and resist multiple antibiotics makes it a significant public health threat. This review highlights the diverse mechanisms by which P. aeruginosa adapts and persists in various environments, focusing on regulatory networks and genotypic-phenotypic variations. Key mechanisms include quorum sensing (QS), motility-sessility switch, biofilm formation, antibiotic resistance, and adaptive radiation. QS plays a central role in coordinating phenotypic changes and virulence factor production, while biofilms provide a protective niche against host defenses and antibiotics. Antibiotic resistance mechanisms, such as efflux pumps and altered cell structures, contribute to the bacterium's survival in clinical settings. The review also discusses the importance of collaborative international efforts to combat the growing threat of P. aeruginosa infections and reduce antibiotic resistance.Pseudomonas aeruginosa is a versatile and opportunistic pathogen that causes significant morbidity and mortality, particularly in immunocompromised patients and those with cystic fibrosis (CF). Its ability to adapt, survive, and resist multiple antibiotics makes it a significant public health threat. This review highlights the diverse mechanisms by which P. aeruginosa adapts and persists in various environments, focusing on regulatory networks and genotypic-phenotypic variations. Key mechanisms include quorum sensing (QS), motility-sessility switch, biofilm formation, antibiotic resistance, and adaptive radiation. QS plays a central role in coordinating phenotypic changes and virulence factor production, while biofilms provide a protective niche against host defenses and antibiotics. Antibiotic resistance mechanisms, such as efflux pumps and altered cell structures, contribute to the bacterium's survival in clinical settings. The review also discusses the importance of collaborative international efforts to combat the growing threat of P. aeruginosa infections and reduce antibiotic resistance.